Measuring the impact of COVID-19 social distancing measures on sexual health behaviours and access to HIV and sexual and reproductive health services for people living with HIV in Botswana.

Africa Botswana COVID—19 HIV—human immunodeficiency virus SARS—cov—2 family planning (FP) sexual and reproductive health

Journal

Frontiers in global women's health
ISSN: 2673-5059
Titre abrégé: Front Glob Womens Health
Pays: Switzerland
ID NLM: 101776281

Informations de publication

Date de publication:
2023
Historique:
received: 29 06 2022
accepted: 22 02 2023
entrez: 27 3 2023
pubmed: 28 3 2023
medline: 28 3 2023
Statut: epublish

Résumé

Uninterrupted access to HIV and sexual and reproductive health (SRH) services is essential, particularly in high HIV prevalence settings, to prevent unintended pregnancy and vertical HIV transmission. Understanding the challenges that COVID-19 and associated social distancing measures (SDMs) posed on health service access is imperative for future planning. This cross-sectional study was conducted in Botswana between January-February 2021. A web-based questionnaire was disseminated on social media as part of the International Sexual Health and REproductive Health (I-SHARE) Survey. Respondents answered questions on SRH, before and during COVID-19 SDMs. Subgroup analysis and comparison of descriptive data was performed for people living with HIV (PLWH). Of 409 participants, 65 were PLWH (80% female, 20% male). During SDMs, PLWH found it more difficult to access condoms and treatment for HIV and STIs; attend HIV appointments; and maintain adherence to antiretroviral therapy. Compared to HIV-negative women, a higher proportion of women living with HIV used condoms as their primary method of contraception (54% vs. 48%), and had lower use of long-acting reversible contraception (8% vs. 14%) and dual contraception (8% vs. 16%). Mirroring global trends, COVID-19 disrupted HIV and SRH service access in Botswana. However, in high HIV-prevalence settings, disruption may more severely impact population health with disproportionate effects on women. Integration of HIV and SRH services could build health system capacity and resilience, reduce missed opportunities for delivering SRH services to PLWH and limit the consequences of future restrictions that may cause health system disruption.

Identifiants

pubmed: 36970120
doi: 10.3389/fgwh.2023.981478
pmc: PMC10030995
doi:

Types de publication

Journal Article

Langues

eng

Pagination

981478

Informations de copyright

© 2023 Ensor, Mechie, Ryan, Mussa, Bame, Tamuthiba, Moshashane and Morroni.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Epidemiol Health. 2021;43:e2021039
pubmed: 34044477
BMC Womens Health. 2015 Nov 13;15:104
pubmed: 26563220
Trans R Soc Trop Med Hyg. 2017 Jan 1;111(1):22-29
pubmed: 28340207
Emerg Infect Dis. 2016 Mar;22(3):433-41
pubmed: 26886846
AIDS. 2019 Dec 15;33 Suppl 3:S213-S226
pubmed: 31490781
Clin Pharmacokinet. 2015 Jan;54(1):23-34
pubmed: 25331712
PLOS Glob Public Health. 2022 Apr 27;2(4):e0000174
pubmed: 36962234
Glob Health Action. 2019;12(1):1662685
pubmed: 31510887
Reprod Health. 2021 Dec 20;18(1):252
pubmed: 34930318
Expert Opin Drug Metab Toxicol. 2013 May;9(5):559-72
pubmed: 23425052
Hum Resour Health. 2014 Aug 07;12:42
pubmed: 25103923
Reprod Health. 2018 Nov 15;15(1):189
pubmed: 30442150
Sex Transm Infect. 2011 Apr;87(3):183-90
pubmed: 21330572
Int J Integr Care. 2017 Jul 12;17(4):1
pubmed: 28970759
Drug Saf. 2016 Nov;39(11):1053-1072
pubmed: 27562873
Global Health. 2019 Jul 24;15(1):49
pubmed: 31340836
Sex Transm Infect. 2016 Mar;92(2):130-4
pubmed: 26438349
PLoS Med. 2021 Nov 9;18(11):e1003836
pubmed: 34752477
Reprod Health. 2019 May 29;16(Suppl 1):61
pubmed: 31138307
Reprod Health. 2019 May 29;16(Suppl 1):58
pubmed: 31138248
BMJ Sex Reprod Health. 2021 Oct;47(4):252-260
pubmed: 33579717
BMC Infect Dis. 2015 Oct 26;15:459
pubmed: 26502723
J Epidemiol Community Health. 2017 Sep;71(9):897-904
pubmed: 28679537
Ann Pharmacother. 2015 Jul;49(7):784-9
pubmed: 25862012
Reprod Health. 2019 May 29;16(Suppl 1):62
pubmed: 31138271
BMC Health Serv Res. 2013 Jan 11;13:18
pubmed: 23311431
PLoS Med. 2021 Oct 18;18(10):e1003831
pubmed: 34662333
N Engl J Med. 2016 Jul 28;375(4):396-8
pubmed: 27331661
PLoS One. 2022 Feb 7;17(2):e0261904
pubmed: 35130289
Sex Transm Infect. 2021 Mar;97(2):88-92
pubmed: 33082232
Reprod Health. 2022 Jan 21;19(1):18
pubmed: 35062968

Auteurs

Samuel Ensor (S)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Imogen Mechie (I)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Rebecca Ryan (R)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Aamirah Mussa (A)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Bame Bame (B)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Lefhela Tamuthiba (L)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Neo Moshashane (N)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Chelsea Morroni (C)

Botswana Sexual and Reproductive Health Initiative, Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
MRC Centre for Reproductive Health and Centre for Global Health, University of Edinburgh, Edinburgh, United Kingdom.

Classifications MeSH